Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Fosphenytoin is a prodrug of phenytoin; conversion to phenytoin likely occurs via phosphatases. Phenytoin is mainly metabolised by CYP2C9 and to a lesser extent by CYP2C19. Lamivudine is eliminated renally.